Receptor protein tyrosine phosphatases are novel components of a polycystin complex

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 10, 2011, Pages 1225-1238

  Boucher, Catherine A ^a   Ward, Heather H ^c   Case, Ruth L ^a   Thurston, Katie S ^a   Li, Xiaohong ^b   Needham, Andrew ^a   Romero, Elsa ^c   Hyink, Deborah ^b   Qamar, Seema ^a   Roitbak, Tamara ^c   Powell, Samantha ^a   Ward, Christopher ^d   Wilson, Patricia D ^b   Wandinger Ness, Angela ^c   Sandford, Richard N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Adherens junctions; G protein coupled signaling; Polycystins; Primary cilium; Tyrosine kinase; Tyrosine phosphatase

Indexed keywords

ALPHA INTEGRIN; CARBOXYPEPTIDASE B; CONNECTIN; HEAT SHOCK TRANSCRIPTION FACTOR 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; POLYCYSTIN 1; POLYCYSTIN 2; UVOMORULIN; ZINC FINGER PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; CELL INTERACTION; CELL JUNCTION; CELL STRAIN HEK293; CILIATED EPITHELIUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; PHAGE DISPLAY; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CADHERINS; CELL LINE; CELL MEMBRANE; HUMANS; KIDNEY; MICE; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; MUTAGENESIS, SITE-DIRECTED; PEPTIDE LIBRARY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRPP CATION CHANNELS;

EID: 80052264443     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.11.006     Document Type: Article

References (98)

1. Kimberling W., Kumar S., Gabow P., Kenyon J., Connolly C., Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993, 18:467-472.
2. Peters D., Spruit L., Saris J., Ravine D., Sandkuijl L., Fossdal R., Boersma J., Van Eijk R., Norby S., Constantinou-Deltas C.D., Pierides A., Briessenden J., Frants R.R., Van Ommen G.-J.B., Breuning M. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat. Genet. 1993, 5:359-362.
3. Germino G., Barton N., Lamb J., Higgs D., Harris P., Xiao G., Scherer G., Nakamura Y., Reeders S. Identification of a locus which shows no genetic recombination with the autosomal dominant polycystic kidney disease gene on chromosome 16. Am. J. Hum. Genet. 1990, 46:925-933.
4. Reeders S., Keith T., Green P., Germino G., Barton N., Lehmann O., Brown V., Phipps P., Morgan J., Bear J., Parfrey P., Barton N., Lehmann O., Brown V., Phipps P., Morgan J., Bear J., Et A. Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics 1988, 3:150-155.
5. Nauli S., Alenghat F., Luo Y., Williams E., Vassilev P., Li X., Elia A., Lu W., Brown E., Quinn S., Ingber D., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
6. Xu C., Rossetti S., Jiang L., Harris P., Brown-Glaberman U., Wandinger-Ness A., Bacallao R., Alper S. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am. J. Physiol. Ren. Physiol. 2007, 292:F930-F945.
7. Le N., Van Der Wal A., Van Der Bent P., Lantinga-Van Leeuwen I.S., Breuning M., Van Dam H., De Heer E., Peters D. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 2005, 16:2724-2731.
8. Parnell S., Magenheimer B., Maser R., Zien C., Frischauf A., Calvet J. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J. Biol. Chem. 2002, 277:19566-19572.
9. Boletta A., Qian F., Onuchic L., Bhunia A., Phakdeekitcharoen B., Hanaoka K., Guggino W., Monaco L., Germino G. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol. Cell 2000, 6:1267-1273.
10. Nickel C., Benzing T., Sellin L., Gerke P., Karihaloo A., Liu Z., Cantley L.G., Walz G. The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells. J. Clin. Invest. 2002, 109:481-489.
11. Hughes J., Ward C., Peral B., Aspinwall R., Clark K., San Millan J.L., Gamble V., Harris P. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 1995, 10:151-160.
12. Geng L., Burrow C., Li H.P., Wilson P. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim. Biophys. Acta 2000, 1535:21-35.
13. Li H., Geng L., Burrow C., Wilson P. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain. Biochem. Biophys. Res. Commun. 1999, 259:356-363.
14. Sandford R., Sgotto B., Aparicio S., Brenner S., Vaudin M., Wilson R., Chissoe S., Pepin K., Bateman A., Chothia C., Hughes J., Harris P. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum. Mol. Genet. 1997, 6:1483-1489.
15. Qian F., Germino F., Cai Y., Zhang X., Somlo S., Germino G. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 1997, 16:179-183.
16. Wilson P.D., Geng L., Li X., Burrow C. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab. Invest. 1999, 79:1311-1323.
17. Bycroft M., Bateman A., Clarke J., Hamill S.J., Sandford R., Thomas R., Chothia C. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J. 1999, 18:297-305.
18. Forman J., Qamar S., Paci E., Sandford R., Clarke J. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J. Mol. Biol. 2005, 349:861-871.
19. Boletta A., Qian F., Onuchic L., Bragonzi A., Cortese M., Deen P., Courtoy P., Soria M., Devuyst O., Monaco L., Germino G. Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am. J. Kidney Dis. 2001, 38:1421-1429.
20. Boulter C., Mulroy S., Webb S., Fleming S., Brindle K., Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12174-12179.
21. Guillaume R., Trudel M. Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes. Mech. Dev. 2000, 93:179-183.
22. Scheffers M., Van Der Bent P., Van De Wal A., Van Eendenburg J., Breuning M., De Heer E., Peters D. Altered distribution and co-localization of polycystin-2 with polycystin-1 in MDCK cells after wounding stress. Exp. Cell Res. 2004, 292:219-230.
23. Silberberg M., Charron A., Bacallao R., Wandinger-Ness A. Mispolarization of desmosomal proteins and altered intercellular adhesion in autosomal dominant polycystic kidney disease. Am. J. Physiol. Ren. Physiol. 2005, 288:F1153-F1163.
24. Wilson P. Polycystic kidney disease. N. Engl. J. Med. 2004, 350:151-164.
25. Hanaoka K., Qian F., Boletta A., Bhunia A., Piontek K., Tsiokas L., Sukhatme V., Guggino W., Germino G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
26. Qamar S., Vadivelu M., Sandford R. TRP channels and kidney disease: lessons from polycystic kidney disease. Biochem. Soc. Trans. 2007, 35:124-128.
27. Woudenberg-Vrenken T.E., Bindels R.J., Hoenderop J. The role of transient receptor potential channels in kidney disease. Nat. Rev. Nephrol. 2009, 5:441-449.
28. Huan Y., Van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J. Clin. Invest. 1999, 104:1459-1468.
29. Roitbak T., Ward C., Harris P., Bacallao R., Ness S., Wandinger-Ness A. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol. Biol. Cell 2004, 15:1334-1346.
30. Yoder B., Hou X., Guay-Woodford L.M. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 2002, 13:2508-2516.
31. Scheffers M., Van Der Bent P., Prins F., Spruit L., Breuning M., Litvinov S., De Heer E., Peters D. Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum. Mol. Genet. 2000, 9:2743-2750.
32. Muller T., Choidas A., Reichmann E., Ullrich A. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 1999, 274:10173-10183.
33. Volberg T., Zick Y., Dror R., Sabanay I., Gilon C., Levitzki A., Geiger B. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J. 1992, 11:1733-1742.
34. Roitbak T., Surviladze Z., Tikkanen R., Wandinger-Ness A. A polycystin multiprotein complex constitutes a cholesterol-containing signalling microdomain in human kidney epithelia. Biochem. J. 2005, 392:29-38.
35. Ma R., Li W., Rundle D., Kong J., Akbarali H., Tsiokas L. PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol. Cell. Biol. 2005, 25:8285-8298.
36. Du J., Wilson P. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 1995, 269:C487-C495.
37. Sweeney W.J., Avner E. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am. J. Physiol. 1998, 275:F387-F394.
38. Wilson S.J., Amsler K., Hyink D., Li X., Lu W., Zhou J., Burrow C., Wilson P. Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta 2006, 1762:647-655.
39. Song X., Di Giovanni V., He N., Wang K., Ingram A., Rosenblum N., Pei Y. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum. Mol. Genet. 2009, 18:2328-2343.
40. Torres V.E., Sweeney W.J., Wang X., Qian Q., Harris P., Frost P., Avner E. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int. 2003, 64:1573-1579.
41. Boca M., Distefano G., Qian F., Bhunia A., Germino G., Boletta A. Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Am. Soc. Nephrol. 2006, 17:637-647.
42. Puri S., Magenheimer B., Maser R., Ryan E., Zien C., Walker D., Wallace D., Hempson S., Calvet J. Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J. Biol. Chem. 2004, 279:55455-55464.
43. Shillingford J., Murcia N., Larson C., Low S., Hedgepeth R., Brown N., Flask C., Novick A.C., Goldfarb D., Kramer-Zucker A., Walz G., Piontek K., Germino G., Weimbs T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5466-5471.
44. Le N., Van Der Bent P., Huls G., Van De Wetering M., Loghman-Adham M., Ong A., Calvet J., Clevers H., Breuning M., Van Dam H., Peters D. Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected. J. Biol. Chem. 2004, 279:27472-27481.
45. Tao Y., Kim J., Schrier R., Edelstein C. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 2005, 16:46-51.
46. Wahl P., Serra A., Le Hir M., Molle K., Hall M., Wuthrich R. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transplant. 2006, 21:598-604.
47. Cai Y., Anyatonwu G., Okuhara D., Lee K., Yu Z., Onoe T., Mei C., Qian Q., Geng L., Wiztgall R., Ehrlich B., Somlo S. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 2004, 279:19987-19995.
48. Fu X., Wang Y., Schetle N., Gao H., Putz M., Von Gersdorff G., Walz G., Kramer-Zucker A.G. The subcellular localization of TRPP2 modulates its function. J. Am. Soc. Nephrol. 2008, 19:1342-1351.
49. Xu H., Zhao H., Tian W., Yoshida K., Roullet J., Cohen D. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J. Biol. Chem. 2003, 278:11520-11527.
50. Kuehn E., Hirt M., John A., Muehlenhardt P., Boehlke C., Putz M., Kramer-Zucker A.G., Bashkurov M., Van De Weyer P.S., Kotsis F., Walz G. Kidney injury molecule 1 (Kim1) is a novel ciliary molecule and interactor of polycystin 2. Biochem. Biophys. Res. Commun. 2007, 364:861-866.
51. Fischer E., Legue E., Doyen A., Nato F., Nicolas J., Torres V., Yaniv M., Pontoglio M. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 2006, 38:21-23.
52. Harris P., Torres V. Polycystic kidney disease. Annu. Rev. Med. 2009, 60:321-337.
53. Bacallao R., Mcneill H. Cystic kidney diseases and planar cell polarity signaling. Clin. Genet. 2009, 75:107-117.
54. Alonso A., Sasin J., Bottini N., Friedberg I., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 2004, 117:699-711.
55. Chagnon M., Uetani N., Tremblay M. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem. Cell Biol. 2004, 82:664-675.
56. Anders L., Mertins P., Lammich S., Murgia M., Hartmann D., Saftig P., Haass C., Ullrich A. Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity. Mol. Cell. Biol. 2006, 26:3917-3934.
57. Pulido R., Serra-Pages C., Tang M., Streuli M. The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:11686-11690.
58. Blanchetot C., Tertoolen L., Overvoorde J., Den Hertog J. Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases. J. Biol. Chem. 2002, 277:47263-47269.
59. Kypta R., Su H., Reichardt L. Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J. Cell Biol. 1996, 134:1519-1529.
60. Flint A., Tiganis T., Barford D., Tonks N. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1680-1685.
61. Siu R., Fladd C., Rotin D. N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth. Mol. Cell. Biol. 2007, 27:208-219.
62. Stoker A.W. Protein tyrosine phosphatases and signalling. J. Endocrinol. 2005, 185:19-33.
63. Thompson K., Uetani N., Manitt C., Elchebly M., Tremblay M., Kennedy T. Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol. Cell. Neurosci. 2003, 23:681-692.
64. Foggensteiner L., Bevan A., Thomas R., Coleman N., Boulter C., Bradley J., Ibraghimov-Beskrovnaya O., Klinger K., Sandford R. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J. Am. Soc. Nephrol. 2000, 11:814-827.
65. Ward C.J., Turley H., Ong A., Comley M., Biddolph S., Chetty R., Ratcliffe P., Gattner K., Harris P. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1524-1528.
66. Isacke C. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 1994, 107:2353-2359.
67. Loghman-Adham M., Nauli S., Soto C., Kariuki B., Zhou J. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts. Am. J. Physiol. Ren. Physiol. 2003, 285:F397-F412.
68. Nauli S., Rossetti S., Kolb R.J., Alenghat F., Consugar M., Harris P., Ingber D., Loghman-Adham M., Zhou J. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J. Am. Soc. Nephrol. 2006, 17:1015-1025.
69. Charron A., Nakamura S., Bacallao R., Wandinger-Ness A. Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J. Cell Biol. 2000, 149:111-124.
70. Clendenon J., Phillips C., Sandoval R., Fang S., Dunn K. Voxx: a PC-based, near real-time volume rendering system for biological microscopy. Am. J. Physiol. Cell Physiol. 2002, 282:C213-C218.
71. Walchli S., Curchod M., Gobert R.P., Arkinstall S., Hooft Van Huijsduijnen R. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate-trapping" mutants. J. Biol. Chem. 2000, 275:9792-9796.
72. Polgar K., Burrow C., Hyink D., Fernandez H., Thornton K., Li X., Gusella G., Wilson P. Disruption of polycystin-1 function interferes with branching morphogenesis of the ureteric bud in developing mouse kidneys. Dev. Biol. 2005, 286:16-30.
73. Wallace M., Fladd C., Batt J., Rotin D. The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma. Mol. Cell. Biol. 1998, 18:2608-2616.
74. Van Adelsberg J., Chamberlain S., D'Agati V. Polycystin expression is temporally and spatially regulated during renal development. Am. J. Physiol. 1997, 272:F602-F609.
75. Boucher C., Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur. J. Hum. Genet. 2004, 12:347-354.
76. Symons J., Levea C.M., Mooney R. Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes. Biochem. J. 2002, 365:513-519.
77. Suarez Pestana E., Tenev T., Gross S., Stoyanov B., Ogata M., Bohmer F. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene 1999, 18:4069-4079.
78. Wei W., Hackmann K., Xu H., Germino G., Qian F. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J. Biol. Chem. 2007, 282:21729-21737.
79. Streuli M., Krueger N., Tsai A., Saito H. A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:8698-8702.
80. Brady-Kalnay S.M., Tonks N. Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol. 1995, 7:650-657.
81. Krueger N., Van Vactor D., Wan H., Gelbart W., Goodman C., Saito H. The transmembrane tyrosine phosphatase DLAR controls motor axon guidance in Drosophila. Cell 1996, 84:611-622.
82. Neel B.G., Tonks N. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 1997, 9:193-204.
83. Ratcliffe C., Qu Y., Mccormick K., Tibbs V., Dixon J., Scheuer T., Catterall W. A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta. Nat. Neurosci. 2000, 3:437-444.
84. Von Wichert G., Jiang G., Kostic A., De Vos K., Sap J., Sheetz M. RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages. J. Cell Biol. 2003, 161:143-153.
85. Lamprianou S., Vacaresse N., Suzuki Y., Meziane H., Buxbaum J., Schlessinger J., Harroch S. Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development. Mol. Cell. Biol. 2006, 26:5106-5119.
86. Bouyain S., Watkins D. The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2443-2448.
87. Uetani N., Chagnon M., Kennedy T., Iwakura Y., Tremblay M. Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J. Neurosci. 2006, 26:5872-5880.
88. Mrug M., Li R., Cui X., Schoeb T., Churchill G., Guay-Woodford L.M. Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. J. Am. Soc. Nephrol. 2005, 16:905-916.
89. Aicher B., Lerch M., Muller T., Schilling J., Ullrich A. Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing. J. Cell Biol. 1997, 138:681-696.
90. Guay-Woodford L.M. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Ren. Physiol. 2003, 285:F1034-F1049.
91. Snell W., Pan J., Wang Q. Cilia and flagella revealed: from flagellar assembly in Chlamydomonas to human obesity disorders. Cell 2004, 117:693-697.
92. Aricescu A., Mckinnell I., Halfter W., Stoker A. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 2002, 22:1881-1892.
93. Duan Y., Giger R. A new role for RPTPsigma in spinal cord injury: signaling chondroitin sulfate proteoglycan inhibition. Sci. Signal. 2010, 3:e6.
94. Liu Q., Tan G., Levenkova N., Li T., Pugh E.J., Rux J., Speicher D., Pierce E. The proteome of the mouse photoreceptor sensory cilium complex. Mol. Cell. Proteomics 2007, 6:1299-1317.
95. Beacham D., Ahn M., Catterall W., Scheuer T. Sites and molecular mechanisms of modulation of Na(v)1.2 channels by Fyn tyrosine kinase. J. Neurosci. 2007, 27:11543-11551.
96. Parnell S., Magenheimer B., Maser R., Calvet J. Identification of the major site of in vitro PKA phosphorylation in the polycystin-1C-terminal cytosolic domain. Biochem. Biophys. Res. Commun. 1999, 259:539-543.
97. Parnell S., Magenheimer B., Maser R., Rankin C., Smine A., Okamoto T., Calvet J. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem. Biophys. Res. Commun. 1998, 251:625-631.
98. Arnould T., Kim E., Tsiokas L., Jochimsen F., Gruning W., Chang J., Walz G. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 1998, 273:6013-6018.